HK1059574A1 - Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture - Google Patents

Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture

Info

Publication number
HK1059574A1
HK1059574A1 HK04102459A HK04102459A HK1059574A1 HK 1059574 A1 HK1059574 A1 HK 1059574A1 HK 04102459 A HK04102459 A HK 04102459A HK 04102459 A HK04102459 A HK 04102459A HK 1059574 A1 HK1059574 A1 HK 1059574A1
Authority
HK
Hong Kong
Prior art keywords
manufacture
processes
controlled
cross
pharmaceutical formulations
Prior art date
Application number
HK04102459A
Other languages
English (en)
Inventor
Vincent Lenaerts
Roland Herwig Friedrich Beck
Elsie Van Bogaert
Francois Chouinard
Reiner Hopcke
Cyril Desevaux
Original Assignee
Vincent Lenaerts
Roland Herwig Friedrich Beck
Elsie Van Bogaert
Francois Chouinard
Reiner Hopcke
Cyril Desevaux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24427807&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1059574(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vincent Lenaerts, Roland Herwig Friedrich Beck, Elsie Van Bogaert, Francois Chouinard, Reiner Hopcke, Cyril Desevaux filed Critical Vincent Lenaerts
Publication of HK1059574A1 publication Critical patent/HK1059574A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B33/00—Preparation of derivatives of amylose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK04102459A 2000-06-29 2004-04-06 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture HK1059574A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/606,399 US6607748B1 (en) 2000-06-29 2000-06-29 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
PCT/US2001/020319 WO2002002084A1 (en) 2000-06-29 2001-06-26 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture

Publications (1)

Publication Number Publication Date
HK1059574A1 true HK1059574A1 (en) 2004-07-09

Family

ID=24427807

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04102459A HK1059574A1 (en) 2000-06-29 2004-04-06 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture

Country Status (27)

Country Link
US (2) US6607748B1 (pt)
EP (1) EP1305009B1 (pt)
JP (1) JP5025066B2 (pt)
KR (1) KR100840393B1 (pt)
CN (1) CN100352509C (pt)
AR (1) AR029549A1 (pt)
AT (1) ATE328585T1 (pt)
AU (2) AU7148101A (pt)
BR (1) BRPI0112140B8 (pt)
CA (1) CA2414349C (pt)
CZ (1) CZ300152B6 (pt)
DE (1) DE60120413T2 (pt)
DK (1) DK1305009T3 (pt)
ES (1) ES2272499T3 (pt)
HK (1) HK1059574A1 (pt)
HU (1) HUP0301302A2 (pt)
IL (2) IL153654A0 (pt)
MX (1) MXPA03000035A (pt)
MY (1) MY128308A (pt)
NO (1) NO20026254L (pt)
NZ (1) NZ523644A (pt)
PL (1) PL202177B1 (pt)
PT (1) PT1305009E (pt)
RU (1) RU2274443C2 (pt)
SI (1) SI1305009T1 (pt)
TW (1) TWI289460B (pt)
WO (1) WO2002002084A1 (pt)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
DE60023122T2 (de) * 1998-10-30 2006-07-13 Rj Innovation Verfahren zur Verhinderung von Hypokalzämie in gebährenden Tieren und hierfür verwendete Zusammensetzungen
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
FR2822471B1 (fr) * 2001-03-26 2003-06-13 Roquette Freres Procede de cuisson/sechage d'amidons riches en amylose
AU2002348105A1 (en) * 2001-10-29 2003-05-12 King Pharmaceuticals Research And Development, Inc Oral dosage forms for improving the bioavailability of therapeutic agents
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
US7887838B2 (en) * 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
US6949256B2 (en) * 2002-01-18 2005-09-27 Banner Pharmacaps, Inc. Non-gelatin capsule shell formulation
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
EP1490036A1 (en) * 2002-03-22 2004-12-29 Cilag AG Sustained release formulation of tramadol
US20030191029A1 (en) * 2002-03-28 2003-10-09 Elementis Specialties, Inc. Aqueous-based oil well drilling fluids containing high amylose starch polymers
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
RU2328275C2 (ru) * 2002-10-25 2008-07-10 Лабофарм Инк. Композиции трамадола пролонгированного высвобождения с 24-часовым действием
MXPA05004410A (es) * 2002-10-25 2005-11-23 Labopharm Inc Composiciones de liberacion controlada.
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
MY142195A (en) * 2002-10-25 2010-10-15 Labopharm Inc Controlled-release compositions
US6846497B2 (en) 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
US20050019295A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
MXPA05011026A (es) * 2003-04-14 2005-12-12 Fmc Corp Pelicula de gel termo-reversible homogenea que contiene carragenano kappa-2 y capsulas blandas hechas a partir de la misma.
US7816341B2 (en) * 2003-04-14 2010-10-19 Fmc Corporation Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
US20050048185A1 (en) * 2003-04-14 2005-03-03 Fmc Corporation Delivery systems of homogeneous, thermoreversible low viscosity polymannan gum films
US20050013847A1 (en) * 2003-04-14 2005-01-20 Fmc Corporation Delivery systems of homogeneous, thermoreversible alginate films
US20050019294A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible alginate films and soft capsules made therefrom
US20050008677A1 (en) * 2003-04-14 2005-01-13 Fmc Corporation Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
EP1479381A1 (en) * 2003-05-19 2004-11-24 Euro-Celtique S.A. Pharmaceutical dosage form comprising a solid solution
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
JP2007533733A (ja) * 2004-04-22 2007-11-22 モル リサーチ アプリケーションズ リミテッド 食物摂取管理の方法
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20060188631A1 (en) * 2005-02-18 2006-08-24 Kyungsoo Woo Pregelatinized chemically modified resistant starch products and uses thereof
JP5269595B2 (ja) 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー １日１回投与用トラゾドン組成物
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
CN100437113C (zh) * 2006-04-11 2008-11-26 汪运山 一种检测血液中非那西丁与醋氨酚浓度比值的试剂盒
WO2009018169A1 (en) * 2007-07-27 2009-02-05 Auspex Pharmaceuticals, Inc. Substituted cyclohexanols
RU2445320C2 (ru) * 2007-08-31 2012-03-20 Сирал Бельгия Нв Способ получения набухающего в холодной воде сшитого фосфатом желатинизированного крахмала
EP2203166B1 (en) * 2007-10-16 2015-05-06 Paladin Labs Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
GB0722484D0 (en) * 2007-11-15 2007-12-27 Ucl Business Plc Solid compositions
JP5651818B2 (ja) 2007-12-17 2015-01-14 パラディン ラブス インコーポレーテッド 誤用を防止するための放出制御製剤
KR101561571B1 (ko) * 2007-12-28 2015-10-19 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 글리코겐과 알긴산염의 회합을 기초로 한 서방형 제제
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
MX2010009067A (es) * 2008-02-19 2010-09-14 Mcneil Ppc Inc Composiciones recubiertas por inmersion que contienen un almidon que tiene alto contenido de amilosa.
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
WO2010028489A1 (en) 2008-09-15 2010-03-18 Labopharm Inc. Starch-based microparticles for the release of agents disposed therein
EP2179727B1 (en) * 2008-10-27 2013-05-29 Roquette Freres Water insoluble polymer: modified starch derivative-based film coatings for colon targeting
AU2009327312A1 (en) 2008-12-16 2011-08-04 Labopharm Europe Limited Misuse preventative, controlled release formulation
GEP20146013B (en) 2009-01-23 2014-01-27 Aziende Chimiche Riunite Angelini Francesco A C R A F S P A It Controlled release pharmaceutical or food formulation and method of preparation thereof
BR112012001244A2 (pt) 2009-07-22 2020-12-08 Gruünenthal Gmbh Forma de dosagem resitente à adulteração, seu processo de produção, e embalagem contendo tal forma
WO2011009602A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Hot-melt extruded controlled release dosage form
AU2010300641B2 (en) 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US9579285B2 (en) 2010-02-03 2017-02-28 Gruenenthal Gmbh Preparation of a powdery pharmaceutical composition by means of an extruder
US20130196028A1 (en) 2010-02-07 2013-08-01 Clearfarma Industries Ltd. Chickpea preparation and uses thereof
EP2386297A1 (en) * 2010-04-28 2011-11-16 Roquette Frères Indigestible polymer: starch acetate -based film coatings for colon targeting
WO2012003968A1 (en) 2010-07-06 2012-01-12 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
AR082862A1 (es) 2010-09-02 2013-01-16 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
PT2736497T (pt) 2011-07-29 2017-11-30 Gruenenthal Gmbh Comprimido resistente a adulteração proporcionando libertação imediata de fármaco
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
WO2013025572A1 (en) * 2011-08-12 2013-02-21 Rutgers, The State University Of New Jersey An interpolymer network delivery system
CA2864949A1 (en) 2012-02-28 2013-09-06 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
ES2692944T3 (es) 2012-04-18 2018-12-05 Grünenthal GmbH Forma de dosificación farmacéutica resistente a la manipulación y resistente a la descarga rápida de la dosis
GB201207907D0 (en) 2012-05-04 2012-06-20 E Therapeutics Plc Treatment of depression
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014085599A1 (en) 2012-11-30 2014-06-05 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
CN103070845B (zh) * 2013-01-14 2014-10-22 北京爱特康科贸有限责任公司 一种淀粉空心胶囊及其制备方法
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105934241B (zh) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 通过低温研磨制备粉末状药物组合物
US9616029B2 (en) 2014-03-26 2017-04-11 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release coated reservoir solid dosage form
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
GB201413832D0 (en) * 2014-08-05 2014-09-17 Tate & Lyle Ingredients Starch compositions useful for thickening aqueous liquids
CA2950148C (en) 2014-06-02 2022-07-12 Tethis, Inc. Modified biopolymers and methods of producing and using the same
CN107889459A (zh) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
MX2018006309A (es) 2015-11-23 2019-09-04 Tethis Inc Particulas recubiertas y metodos de fabricacion y uso de las mismas.
CN106337030A (zh) * 2016-08-24 2017-01-18 宁波枫叶杰科生物技术有限公司 一种治理重金属污染盐碱地的微生物制品及其制造方法
JP6216088B1 (ja) * 2017-04-21 2017-10-18 森永製菓株式会社 口腔徐放用組成物及びその製造方法
GB2567493B (en) * 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
CN113121709B (zh) * 2019-12-30 2022-08-26 仙乐健康科技股份有限公司 一种变性淀粉的制备方法及应用
CN112098408B (zh) * 2020-09-14 2022-12-09 湖北亿纬动力有限公司 一种羧甲基纤维素钠溶解效果的检测方法及应用
CN117530929B (zh) * 2024-01-10 2024-03-29 东华大学 一种减肥胶囊

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2938901A (en) 1954-08-06 1960-05-31 Corn Products Co Surgical dusting powder and process therefor
US2987445A (en) 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3034911A (en) 1959-03-25 1962-05-15 Nat Starch Chem Corp Tablet disintegrants
US3453368A (en) 1966-01-13 1969-07-01 Hoffmann La Roche Smaller high potency compressed tablets of ascorbic acid
US3490742A (en) 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4072535A (en) 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US3904601A (en) * 1972-12-21 1975-09-09 Nat Starch Chem Corp Hydroxypropylated, inhibited high amylose retort starches
US4026986A (en) 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
GB1576475A (en) * 1977-01-19 1980-10-08 Unilever Ltd Absorbent cross-linked starch materials
US4308251A (en) 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4369308A (en) 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4818542A (en) 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4551177A (en) 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules
US4904476A (en) 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
GB8812490D0 (en) 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
CA2041774C (en) 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
CA2032385A1 (en) 1990-12-17 1992-06-18 Chung Wai-Chiu Enzymatically debranched starches as tablet excipients
JP3647859B2 (ja) 1992-07-24 2005-05-18 ラボファーム・インコーポレーテッド 酵素的に制御された薬剤放出のための架橋されたポリヒドロキシ材料
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
US5830884A (en) 1995-01-18 1998-11-03 National Starch And Chemical Investment Holding Corporation Pharmaceutical products containing thermally-inhibited starches
JP3949746B2 (ja) * 1996-02-28 2007-07-25 日澱化學株式会社 硝子繊維集束剤用化工澱粉
US5879707A (en) 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
US5807575A (en) * 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture

Also Published As

Publication number Publication date
TWI289460B (en) 2007-11-11
CN100352509C (zh) 2007-12-05
KR20030031504A (ko) 2003-04-21
JP2004501957A (ja) 2004-01-22
CA2414349A1 (en) 2002-01-10
PL202177B1 (pl) 2009-06-30
NO20026254D0 (no) 2002-12-27
AU2001271481B2 (en) 2005-05-26
BR0112140B1 (pt) 2013-04-30
EP1305009A1 (en) 2003-05-02
US20040013726A1 (en) 2004-01-22
BR0112140A (pt) 2003-10-07
RU2274443C2 (ru) 2006-04-20
PT1305009E (pt) 2006-10-31
ES2272499T3 (es) 2007-05-01
DE60120413D1 (de) 2006-07-20
HUP0301302A2 (en) 2003-08-28
SI1305009T1 (sl) 2007-08-31
AR029549A1 (es) 2003-07-02
KR100840393B1 (ko) 2008-06-23
IL153654A (en) 2008-12-29
DE60120413T2 (de) 2007-06-14
DK1305009T3 (da) 2006-12-27
JP5025066B2 (ja) 2012-09-12
CZ20024269A3 (cs) 2003-06-18
WO2002002084A8 (en) 2002-04-04
MY128308A (en) 2007-01-31
BRPI0112140B8 (pt) 2021-05-25
US6607748B1 (en) 2003-08-19
MXPA03000035A (es) 2005-09-21
CZ300152B6 (cs) 2009-02-25
ATE328585T1 (de) 2006-06-15
CN1449279A (zh) 2003-10-15
CA2414349C (en) 2008-09-16
EP1305009A4 (en) 2004-11-17
PL365634A1 (en) 2005-01-10
WO2002002084A1 (en) 2002-01-10
IL153654A0 (en) 2003-07-06
NZ523644A (en) 2005-10-28
NO20026254L (no) 2003-02-27
EP1305009B1 (en) 2006-06-07
AU7148101A (en) 2002-01-14

Similar Documents

Publication Publication Date Title
IL153654A0 (en) Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
MXPA03005923A (es) Derivados de glupopiranosiloxipirazol y su uso en medicinas.
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
HUP0301269A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
HUP0302997A3 (en) Phenylalanine derivatives with alpha4-integrin effect, pharmaceutical compositions containing them and their use
HUP0301042A3 (en) Pharmaceutical composition useful in contraception
HUP0303069A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and their use
AU2001271583A1 (en) Absorbent article tablet
IL151496A0 (en) Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
EP1257255A4 (en) THERAPEUTIC PRODUCT, ITS USE AND MANUFACTURE
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
PL366067A1 (en) Oxayolidinone tablet formulation
HUP0202223A3 (en) Pseudomycin prodrugs, pharmaceutical compositions comprising thereof and their use
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
HUP0204579A3 (en) Pyrrolopyridazine derivatives, pharmaceutical compositions containing them and their use
IL155055A0 (en) Triazole derivatives and pharmaceutical compositions comprising them
AU2001235364A1 (en) Tetrahydronaphtalene derivatives and their use
AU3632901A (en) Sustained release tablet formulations comprising clarithromycin
GB0020379D0 (en) Enzyme composition in tablet form
EP1437363A4 (en) MEDICINAL TRANSPORT AND USE THEREOF
AUPQ711400A0 (en) Improvements in tablet manufacture

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20210629